Table 1 Demographic and clinical variables with comorbidities distribution according to BMI level
From: The impact of obesity in hospitalized patients with COVID-19: a retrospective cohort study
Variable | Total (n = 2547) | Underweight (n = 75, 2.9%) | Eutrophic (n = 847, 33.3%) | Overweight (n = 878, 34.5%) | Class I obesity (n = 396, 15.5%) | Class II obesity (n = 171, 6.7%) | Class III obesity (n = 180, 7.1%) | p |
|---|---|---|---|---|---|---|---|---|
Age (years), mean (± SD) | 60.3 (15.7) | 60.6 (22.0) | 60.7 (15.7) | 63.7 (14.8) | 58.16 (14.5) | 55.2 (14.4) | 50.9 (14.9) | < 0.001(1) |
Male sex, no. (%) | 1431 (56.2) | 44 (58.7) | 535 (63.2) | 516 (58.8) | 197 (49.8) | 66 (28.6) | 73 (40.6) | < 0.001(2) |
Race, no. (%) | 0.075(2) | |||||||
White | 1603 (65.2) | 44 (63.8) | 535 (65.6) | 574 (68.0) | 236 (60.5) | 107 (64.1) | 107 (62.8) | |
Black | 183 (7.5) | 8 (11.6) | 62 (7.6) | 54 (6.4) | 28 (7.2) | 14 (8.4) | 17 (9.9) | |
Brown | 643 (26.2) | 14 (20.3) | 207 (25.4) | 207 (24.5) | 123 (31.5) | 45 (27.0) | 47 (27.5) | |
Asian | 28 (1.1) | 3 (4.4) | 12 (1.5) | 9 (1.1) | 3 (0.8) | 1 (0.6) | 0 (0.0) | |
SAPS-3, mean (± SD) | 65.3 (16.5) | 61.6 (13.7) | 65.0 (15.5) | 67.6 (16.6) | 64.4 (17.7) | 63.2 (17.4) | 59.9 (16.9) | < 0.001(1) |
Comorbidities, no. (%) | ||||||||
Previous cardiovascular disease | 529 (20.8) | 14 (18.7) | 182 (21.5) | 194 (22.1) | 82 (20.7) | 29 (17.0) | 28 (15.8) | 0.348(2) |
Hypertension | 1530 (60.1) | 29 (38.7) | 459 (54.3) | 552 (62.9) | 253 (63.9) | 118 (69.0) | 119 (66.1) | < 0.001(2) |
Arrhythmia | 134 (6.7) | 3 (5.5) | 48 (7.3) | 55 (7.4) | 16 (5.4) | 8 (6.5) | 4 (3.7) | 0.654(2) |
COPD | 186 (7.3) | 8 (10.7) | 65 (7.7) | 75 (8.6) | 18 (4.6) | 8 (4.7) | 12 (6.7) | 0.083(2) |
Asthma | 104 (4.1) | 1 (1.3) | 31 (3.7) | 21 (2.4) | 20 (5.1) | 11 (6.4) | 20 (11.1) | < 0.001(2) |
Dialysis CKD | 87 (3.4) | 7 (9.3) | 40 (4.7) | 25 (2.9) | 9 (2.3) | 3 (1.8) | 3 (1.7) | 0.003(2) |
Non-dialysis CKD | 245 (9.6) | 10 (13.3) | 92 (10.9) | 85 (9.7) | 41 (10.4) | 11 (6.4) | 6 (3.3) | 0.022(2) |
Liver disease | 74 (2.9) | 0 (0.0) | 32 (3.8) | 23 (2.6) | 10 (2.5) | 6 (3.5) | 3 (1.7) | 0.287(2) |
Previous stroke or TIA | 207 (8.1) | 7 (9.3) | 82 (9.7) | 84 (9.6) | 24 (6.1) | 5 (2.9) | 5 (2.8) | < 0.001(2) |
Transplant | 82 (20.3) | 4 (25.0) | 34 (24.8) | 24 (17.5) | 12 (20.0) | 6 (20.7) | 2 (8.0) | 0.423(2) |
Type 2 diabetes | 986 (38.7) | 14 (18.7) | 287 (33.9) | 354 (40.4) | 175 (44.2) | 79 (46.2) | 77 (42.8) | < 0.001(2) |
Dyslipidemia | 172 (37.2) | 3 (25.0) | 42 (30.4) | 74 (43.0) | 28 (39.4) | 15 (38.5) | 10 (33.3) | 0.275(2) |
History of venous thrombosis | 77 (20.2) | 4 (30.8) | 26 (20.5) | 25 (19.8) | 12 (19.7) | 5 (17.9) | 5 (18.5) | 0.957(2) |
Solid cancer | 285 (11.8) | 21 (31.3) | 116 (14.0) | 92 (11.0) | 34 (9.2) | 14 (8.6) | 8 (5.0) | < 0.001(2) |
Leukemia, lymphoma or myeloma | 87 (4.4) | 3 (5.6) | 33 (5.0) | 37 (5.0) | 4 (1.4) | 6 (4.9) | 4 (3.7) | 0.157(2) |
Congenital immunodeficiency | 43 (6.6) | 0 (0.0) | 17 (8.6) | 14 (6.1) | 7 (6.5) | 4 (7.7) | 1 (1.9) | 0.308(3) |
HIV | 35 (1.4) | 5 (6.7) | 14 (1.7) | 7 (0.8) | 4 (1.0) | 4 (2.3) | 1 (0.6) | 0.018(3) |
Current smoking | 184 (7.2) | 4 (5.3) | 68 (8.1) | 62 (7.1) | 27 (6.8) | 8 (4.7) | 15 (8.4) | 0.647(2) |
Former smoking | 587 (23.1) | 17 (22.7) | 193 (22.9) | 220 (25.1) | 83 (21.1) | 41 (24.1) | 33 (18.3) | 0.375(2) |